Tilray Revenue and Competitors
Estimated Revenue & Valuation
- Tilray's estimated annual revenue is currently $563.6M per year.
- Tilray received $100.0M in venture funding in October 2018.
- Tilray's estimated revenue per employee is $928,534
- Tilray's total funding is $48.6M.
- Tilray's current valuation is $3.3B. (January 2022)
- Tilray has 607 Employees.
- Tilray grew their employee count by -2% last year.
What Is Tilray?
Tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. We are the only GMP certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in Australia, Canada, the European Union and the Americas.keywords:N/A
Number of Employees
Employee Growth %
With the prospect of eventual U.S. federal legalization, Tilray has also been busy expanding its footprint south of the border, a factor noted...
Tilray is the cannabis market leader in Canada, where recreational marijuana use has already been legalized. It also has brands well positioned...
The 2021 merger between two strong cannabis companies, Tilray ( TLRY -0.19% ) and Aphria, is turning out to be fruitful.
Tilray Announces Adjournment of Special Meeting of Stockholders to September 10, 2021 Votes already cast point to support for both the Authorized Shares Proposal and the Governance Proposals Tilray urges stockholders to vote immediately in support of long-term value creation NEW YORK & LEAMING ...
TILRAY ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS TO SEPTEMBER 10, 2021 Votes already cast point to support for both the Authorized Shares Proposal and the Governance Proposals Tilray urges stockholders to vote immediately in support of long-term value creation NEW YORK & LEAMIN ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|